Cargando…
Risk of COVID-19 in dermatologic patients receiving long-term immunomodulatory therapy
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
by the American Academy of Dermatology, Inc.
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7329682/ https://www.ncbi.nlm.nih.gov/pubmed/32622141 http://dx.doi.org/10.1016/j.jaad.2020.06.999 |
| _version_ | 1783552948075233280 |
|---|---|
| author | Holcomb, Zachary E. Santillan, Monica Rosales Morss-Walton, Peyton C. Salian, Prerna Her, Min Ji Giannotti, Nicole M. Kimball, Alexa B. Porter, Martina L. |
| author_facet | Holcomb, Zachary E. Santillan, Monica Rosales Morss-Walton, Peyton C. Salian, Prerna Her, Min Ji Giannotti, Nicole M. Kimball, Alexa B. Porter, Martina L. |
| author_sort | Holcomb, Zachary E. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7329682 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | by the American Academy of Dermatology, Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-73296822020-07-02 Risk of COVID-19 in dermatologic patients receiving long-term immunomodulatory therapy Holcomb, Zachary E. Santillan, Monica Rosales Morss-Walton, Peyton C. Salian, Prerna Her, Min Ji Giannotti, Nicole M. Kimball, Alexa B. Porter, Martina L. J Am Acad Dermatol Research Letter by the American Academy of Dermatology, Inc. 2020-10 2020-07-02 /pmc/articles/PMC7329682/ /pubmed/32622141 http://dx.doi.org/10.1016/j.jaad.2020.06.999 Text en © 2020 by the American Academy of Dermatology, Inc. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Research Letter Holcomb, Zachary E. Santillan, Monica Rosales Morss-Walton, Peyton C. Salian, Prerna Her, Min Ji Giannotti, Nicole M. Kimball, Alexa B. Porter, Martina L. Risk of COVID-19 in dermatologic patients receiving long-term immunomodulatory therapy |
| title | Risk of COVID-19 in dermatologic patients receiving long-term immunomodulatory therapy |
| title_full | Risk of COVID-19 in dermatologic patients receiving long-term immunomodulatory therapy |
| title_fullStr | Risk of COVID-19 in dermatologic patients receiving long-term immunomodulatory therapy |
| title_full_unstemmed | Risk of COVID-19 in dermatologic patients receiving long-term immunomodulatory therapy |
| title_short | Risk of COVID-19 in dermatologic patients receiving long-term immunomodulatory therapy |
| title_sort | risk of covid-19 in dermatologic patients receiving long-term immunomodulatory therapy |
| topic | Research Letter |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7329682/ https://www.ncbi.nlm.nih.gov/pubmed/32622141 http://dx.doi.org/10.1016/j.jaad.2020.06.999 |
| work_keys_str_mv | AT holcombzacharye riskofcovid19indermatologicpatientsreceivinglongtermimmunomodulatorytherapy AT santillanmonicarosales riskofcovid19indermatologicpatientsreceivinglongtermimmunomodulatorytherapy AT morsswaltonpeytonc riskofcovid19indermatologicpatientsreceivinglongtermimmunomodulatorytherapy AT salianprerna riskofcovid19indermatologicpatientsreceivinglongtermimmunomodulatorytherapy AT herminji riskofcovid19indermatologicpatientsreceivinglongtermimmunomodulatorytherapy AT giannottinicolem riskofcovid19indermatologicpatientsreceivinglongtermimmunomodulatorytherapy AT kimballalexab riskofcovid19indermatologicpatientsreceivinglongtermimmunomodulatorytherapy AT portermartinal riskofcovid19indermatologicpatientsreceivinglongtermimmunomodulatorytherapy |